Beryl Drugs Ltd Q2 FY2024-2025 Results: Summary
Revenue | ₹5.65Cr |
Net Profits | ₹0.01Cr |
Net Profit Margins | 0.18% |
Highlights
Revenue:
Beryl Drugs Ltd’s revenue fell -30.16% since last year same period to ₹5.65Cr in the Q2 2024-2025. On a quarterly growth basis, Beryl Drugs Ltd has generated -10.17% fall in its revenue since last 3-months.
Net Profits:
Beryl Drugs Ltd’s net profit fell -96.3% since last year same period to ₹0.01Cr in the Q2 2024-2025. On a quarterly growth basis, Beryl Drugs Ltd has generated -97.3% fall in its net profits since last 3-months.
Net Profit Margins:
Beryl Drugs Ltd’s net profit margin fell -94.7% since last year same period to 0.18% in the Q2 2024-2025. On a quarterly growth basis, Beryl Drugs Ltd has generated -96.99% fall in its net profit margins since last 3-months.
